Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever
NCT: NCT05152524 · COMPLETED
Brief Summary
The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.
Frequently Asked Questions
What is Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever?
Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever is a clinical trial registered under NCT05152524. Current status: COMPLETED.
What is the status of NCT05152524?
The current status of NCT05152524 (Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever) is: COMPLETED.
When did Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever start?
Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever started on 2022-03-25.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.